Rainier Client Coverage & Content

Read Coverage

Alt-Meat: What's Under the Lid?

What's Under the Lid? 

Repurposing and adapting pharma bioreactors has enabled the industry to prove fundamental processes and products, but the time for purpose-built machines has arrived, says Hamid Noori, CEO and founder of The Cultivated B, a bioengineering firm.

Read Coverage

Food Ingredients First: Alt-Seafood Acceptance: Visual Appeal Is Paramount

Alt-Seafood Acceptance: Visual Appeal Is Paramount

The alternative seafood sector has evolved dynamically in the last 12 months. From an increased focus on sustainability and ethical sourcing to advancements in texture and flavor profiling, the sector has matured significantly. Interest in plant-based and alternative proteins has been rising for many years, but the seafood sector is brimming with advancements as consumers seek variation to traditional from standard hamburger and nugget analogs.

The World of Food Ingredients explores this space, speaking with pioneering companies, such as The Cultivated B, in cell-based development.

Read Coverage

The Cell Base: The Cultivated B unveils bioreactor control software

The Cultivated B unveils bioreactor control software

The Cultivated B (TCB) has announced its new bioreactor monitoring and control software, set to “revolutionise” bioprocessing with user-friendly, remote capabilities.

The new tech enables a real-time, application-based, personalised user interface with added remote accessibility for its AUXO V bioreactors. The software, which is accessible via the control tower or remotely via phone- and web-based software, marks a leap forward in the cell-based meat industry, offering convenience, flexibility and efficiency for expert and non-expert users to manage bioprocesses.

Read Coverage

Food Matters Live: Biotech company The Cultivated B enters pre-submission process for cultured meat approval in Europe

Biotech company The Cultivated B enters pre-submission process for cultured meat approval in Europe

The Cultivated B (TCB), a biotech company based in Germany and North America, has started discussions with the European Food Safety Authority (EFSA) and officially entered the pre-submission process for novel food approval. Once it submits its dossier for approval of its cultured meat sausages, it will become the first company to apply for EFSA certification for a cultivated product.

Read Coverage

Alt-Meat: Cultivated B to advance commercial scale production

Cultivated B to advance commercial scale production

Germany's cultivated meat firm The Cultivated B today announced a partnership with German cell-tech company denovoMATRIX to conduct a feasibility study into the scalable commercial production of cultivated meat.

Read Coverage

The Cell Base: The Cultivated B’s industrial-grade bioreactor signals commercial viability for cellular agriculture

The Cultivated B’s industrial-grade bioreactor signals commercial viability for cellular agriculture

The Cultivated B's industrial-grade bioreactor signals commercial viability for cellular agriculture as discussed in The Cell Base. 

Read Coverage

Food in Canada: The Cultivated B breaks another barrier in cell-ag with new industrial-grade bioreactor

The Cultivated B breaks another barrier in cell-ag with new industrial-grade bioreactor

Food in Canada discusses The Cultivated B's rapid-delivery manufacturing with its AUXO V industrial-grade bioreactor to address the cellular agriculture industry’s urgent need to increase global capacity in order to reach commercially viability.